The 1938 law enhancing drug regulation and labeling is known as which act?

The 1938 law enhancing drug regulation and labeling is known as which act?

• A. Kefauver-Harris Amendments
• B. Federal Food, Drug, and Cosmetic Act
• C. Pure Food and Drug Act
• D. Drug Price Competition and Patent Term Restoration Act

Answer: (D)

The main concept here is recognizing the federal statute that first established comprehensive drug regulation and labeling in the United States. In 1938, after public health tragedies, Congress passed the Federal Food, Drug, and Cosmetic Act. It expanded federal oversight beyond the 1906 Pure Food and Drug Act by requiring that new drugs be proven safe before they could be marketed, mandating clear labeling with directions and risk information, and giving the FDA authority to inspect manufacturing facilities. This act laid the foundation for modern drug regulation and labeling. The Kefauver-Harris amendments came later in the 1960s to require evidence of efficacy and informed consent. The Pure Food and Drug Act predates 1938 and laid the groundwork but did not provide the same labeling safeguards. The Drug Price Competition and Patent Term Restoration Act from 1984 focused on generic drug entry and patent terms, not regulatory labeling in 1938.

The main concept here is recognizing the federal statute that first established comprehensive drug regulation and labeling in the United States. In 1938, after public health tragedies, Congress passed the Federal Food, Drug, and Cosmetic Act. It expanded federal oversight beyond the 1906 Pure Food and Drug Act by requiring that new drugs be proven safe before they could be marketed, mandating clear labeling with directions and risk information, and giving the FDA authority to inspect manufacturing facilities. This act laid the foundation for modern drug regulation and labeling. The Kefauver-Harris amendments came later in the 1960s to require evidence of efficacy and informed consent. The Pure Food and Drug Act predates 1938 and laid the groundwork but did not provide the same labeling safeguards. The Drug Price Competition and Patent Term Restoration Act from 1984 focused on generic drug entry and patent terms, not regulatory labeling in 1938.